Napolitano, S., Matrone, N., Muddassir, A. L., Martini, G., Sorokin, A., De Falco, V., . . . Troiani, T. (2019). Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression. J Exp Clin Cancer Res.
Chicago Style CitationNapolitano, S., et al. "Triple Blockade of EGFR, MEK and PD-L1 Has Antitumor Activity in Colorectal Cancer Models With Constitutive Activation of MAPK Signaling and PD-L1 Overexpression." J Exp Clin Cancer Res 2019.
MLA CitationNapolitano, S., et al. "Triple Blockade of EGFR, MEK and PD-L1 Has Antitumor Activity in Colorectal Cancer Models With Constitutive Activation of MAPK Signaling and PD-L1 Overexpression." J Exp Clin Cancer Res 2019.